Inventor · disambiguated record
Ingrid Teige
Also filed as: TEIGE INGRID
11 granted patents·10 pending applications·66 citations·filing 2010–2025
86Inventor score
Top patents by PatentIndex Score
21 records- 0189US9266952B2Antibodies against ROR1 and uses thereofTEIGE INGRID·Filed 2011·Granted Feb 23, 2016·27 cites·6 claims
- 0287US9150647B2Biological inhibitors of ROR1 capable of inducing cell deathMELLSTEDT HAKAN·Filed 2010·Granted Oct 6, 2015·33 cites·5 claims
- 0385US11623005B2Combined use of FcγRIIb (CD32B) and CD20 specific antibodiesUNIV SOUTHAMPTON·Filed 2019·Granted Apr 11, 2023·3 cites·5 claims
- 0473US11447549B2Combination of a Treg depleting anti-4-1BB antibody and anti-PD1 antibodyBIOINVENT INT AB·Filed 2018·Granted Sep 20, 2022·1 cites·14 claims
- 0571US2025066492A1Agonistic anti tnfr2 antibody moleculesBIOINVENT INT AB·Filed 2024·Application pending·0 cites
- 0670US2021346498A1Combined use of fc gamma riib (cd32b) and cd20 specific antibodiesUNIV SOUTHAMPTON·Filed 2021·Application pending·0 cites
- 0769US2025388690A1Novel antagonistic anti-tnfr2 antibodiesBIOINVENT INT AB·Filed 2025·Application pending·0 cites
- 0865US10525129B2Combined use of Fc gamma RIIb (CD32B) and CD20-specific antibodiesCRAGG MARK·Filed 2011·Granted Jan 7, 2020·2 cites·32 claims
- 0964US12291569B2Antibodies and nucleotide sequences, and uses thereofBIOINVENT INT AB·Filed 2019·Granted May 6, 2025·0 cites·8 claims
- 1064US2025257135A1Novel antibodies and nucleotide sequences, and uses thereofBIOINVENT INT AB·Filed 2025·Application pending·0 cites
- 1163US12139547B2Agonistic anti TNFR2 antibody moleculesBIOINVENT INT AB·Filed 2019·Granted Nov 12, 2024·0 cites·29 claims
- 1263US2023058227A1Novel antibodies and combined use of a treg depleting antibody and an immunostimulatory antibodyBIOINVENT INT AB·Filed 2022·Application pending·0 cites
- 1362US12441805B2Antagonistic anti-TNFR2 antibodiesBIOINVENT INT AB·Filed 2019·Granted Oct 14, 2025·0 cites·29 claims
- 1460US9803013B2Biological materials and uses thereofBIOINVENT INT AB·Filed 2014·Granted Oct 31, 2017·0 cites·15 claims
- 1558US2025326849A1COMBINATION OF A FcyRIIB- AND A TUMOR ANTIBODY FOR USE IN THE TREATMENT OF AN FcyRIIB-NEGATIVE CANCERUNIV SOUTHAMPTON·Filed 2023·Application pending·0 cites
- 1657US2024301070A1Improving antibody tolerability associated with intravenous administrationBIOINVENT INT AB·Filed 2021·Application pending·0 cites
- 1757US2023322933A1Model for prediction of tolerability issues in connection with intravenous administration of therapeutic antibodiesBIOINVENT INT AB·Filed 2021·Application pending·0 cites
- 1853US2024092912A1Novel combinations of antibodies and uses thereofBIOINVENT INT AB·Filed 2022·Application pending·0 cites
- 1946US12344673B2Medicaments, uses and methodsBIOINVENT INT AB·Filed 2015·Granted Jul 1, 2025·0 cites·14 claims
- 2046US2022259309A1Antibody combinations for treatment of cancer in specific patientsBIOINVENT INT AB·Filed 2020·Application pending·0 cites
- 2144US12371498B2Combination and use of antibodiesBIOINVENT INT AB·Filed 2019·Granted Jul 29, 2025·0 cites·16 claims
Join the waitlist — get patent alerts
Get an alert when Ingrid Teige files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →